We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
-5.56%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$42.6B
AUM Growth
-$3.68B
(-8%)
Cap. Flow
-$430M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
14.5%
Holding
923
New
31
Increased
229
Reduced
432
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$95.7M |
| 2 |
Incyte
INCY
|
+$78.3M |
| 3 |
Wells Fargo
WFC
|
+$66.4M |
| 4 |
UGI
UGI
|
+$62.2M |
| 5 |
Winnebago Industries
WGO
|
+$36.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$87.7M |
| 2 |
L3Harris
LHX
|
+$83.8M |
| 3 |
Allstate
ALL
|
+$76.4M |
| 4 |
Murphy USA
MUSA
|
+$74.1M |
| 5 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$73.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.86% |
| 2 | Healthcare | 17.54% |
| 3 | Technology | 13.57% |
| 4 | Consumer Discretionary | 11.77% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$365B
| $977M | 2.29% |
11,341,795
-982,417
| -8% | -$87.7M |
|
2
Pfizer
PFE
$159B
| $837M | 1.97% |
19,132,145
-203,405
| -1% | -$9.88M |
|
3
Bristol-Myers Squibb
BMY
$136B
| $705M | 1.66% |
9,919,455
-56,798
| -0.6% | -$4.12M |
|
4
Verizon
VZ
$208B
| $589M | 1.38% |
15,502,062
+118,875
| +0.8% | +$5.29M |
|
5
ExxonMobil
XOM
$640B
| $562M | 1.32% |
6,441,820
+359,670
| +6% | +$32.8M |
|
6
CVS Health
CVS
$119B
| $550M | 1.29% |
5,770,066
+63,102
| +1% | +$6.25M |
|
7
Amgen
AMGN
$233B
| $523M | 1.23% |
2,318,586
-20,930
| -0.9% | -$5.07M |
|
8
Intel
INTC
$476B
| $499M | 1.17% |
19,358,044
-513,589
| -3% | -$17.5M |
|
9
Kroger
KR
$35.3B
| $483M | 1.14% |
11,046,415
+105,900
| +1% | +$5.03M |
|
10
Oracle
ORCL
$437B
| $448M | 1.05% |
7,343,168
-145,353
| -2% | -$10.6M |
|
11
McKesson
MCK
$104B
| $447M | 1.05% |
1,314,052
-203,861
| -13% | -$70.8M |
|
12
Ameriprise Financial
AMP
$49.6B
| $434M | 1.02% |
1,723,206
-35,451
| -2% | -$9.33M |
|
13
Cummins
CMI
$77.9B
| $424M | 1% |
2,082,812
+6,089
| +0.3% | +$1.3M |
|
14
IBM
IBM
$222B
| $416M | 0.98% |
3,503,749
+33,300
| +1% | +$4.37M |
|
15
Gilead Sciences
GILD
$180B
| $412M | 0.97% |
6,682,529
+135,802
| +2% | +$8.56M |
|
16
AT&T
T
$178B
| $393M | 0.92% |
25,622,553
+848,113
| +3% | +$15.4M |
|
|
17
Allstate
ALL
$65.9B
| $382M | 0.9% |
3,070,446
-614,615
| -17% | -$76.4M |
|
18
Molson Coors Class B
TAP
$7.73B
| $373M | 0.88% |
7,768,804
+239,558
| +3% | +$13M |
|
19
Citigroup
C
$223B
| $371M | 0.87% |
8,906,186
+12,400
| +0.1% | +$613K |
|
20
AbbVie
ABBV
$452B
| $370M | 0.87% |
2,757,962
-109,956
| -4% | -$15.8M |
|
21
HP
HPQ
$27.4B
| $353M | 0.83% |
14,165,046
+139,712
| +1% | +$4.29M |
|
22
Aflac
AFL
$58.5B
| $345M | 0.81% |
6,143,111
-121,580
| -2% | -$7.15M |
|
23
Morgan Stanley
MS
$337B
| $339M | 0.8% |
4,285,276
-61,040
| -1% | -$5.14M |
|
24
Cisco
CSCO
$433B
| $337M | 0.79% |
8,418,706
+378,921
| +5% | +$16.8M |
|
25
Regions Financial
RF
$25.9B
| $333M | 0.78% |
16,581,731
+74,000
| +0.4% | +$1.56M |
|
Similar funds
HF
LSV Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, LSV Asset Management held 923 positions worth $42.6B, down 8% from $46.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
LSV Asset Management's Q3 2022 filing shows 31 new, 229 increased, 432 reduced and 51 closed positions. Its largest new stake was WaFd: 583,608 shares worth $17.5M. The largest sale was Merck, an estimated $87.7M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- LSV Asset Management's largest Q3 2022 buy was WaFd: 583,608 shares worth $17.5M.
- LSV Asset Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $95.7M increase.
- LSV Asset Management's biggest Q3 2022 reduction was Merck, cutting an estimated $87.7M.
- LSV Asset Management fully exited Crown Holdings in Q3 2022, selling an estimated $60.5M.
- LSV Asset Management's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2022.
- LSV Asset Management opened 31 new positions and closed 51 in Q3 2022.
- LSV Asset Management's portfolio value fell 8% quarter-over-quarter to $42.6B.
Based on LSV Asset Management's 13F filing for Q3 2022, filed 4 Nov 2022.